Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.1, 2002-02, pp. : 103-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Features in the Treatment of Androgen-Independent Prostate Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1215-1224

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging targets for the treatment of scleroderma

By Leask Andrew

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Emerging Targets for the Treatment of Dyslipidemia

Current Medicinal Chemistry, Vol. 18, Iss. 6, 2011-02 ,pp. : 909-922

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for the treatment of benign prostatic obstruction

By Hashim Hashim Abrams Paul

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 159-174

Informa Healthcare

Access to resources Recommend Favorite